RESEARCH FINDINGS USING GUIDED
IMAGERY FOR
HYPERTENSION
August, 2006
Dimensions of the problem
Hypertension (HTN) is defined as a repeated blood pressure
reading of greater than 140/90 mm Hg. An estimated 50
million Americans have HTN, and over 31% of those who have
it don’t know it. In approximately 90-95% of HTN,
there is no specific physiological cause found (High “Blood
Pressure Statistics,” undated).
These cases are classified as essential or idiopathic.
Predisposing factors include obesity, smoking, diets high
in fat or salt, other co-existing conditions including
diabetes, and a number of genetic, environmental, and
behavioral factors (DiGuiseppi, 1996).
Costs
The
direct and indirect cost of hypertension in 2000 was $50.3
billion --approximately $37.2 billion in direct costs;
$13.1 billion in indirect costs (“Heart Disease and Stroke
Statistics,” 2002). HTN is a major contributor to
coronary artery disease (740,000 deaths per year in
U.S.A.), cerebrovascular disease (150,000 deaths per year),
and kidney disease - three of the leading causes of
morbidity, mortality, and medical resource utilization in
the USA (Dawber, 1980).
According to the National Center for Health Statistics,
there were 35 million outpatient visits for hypertension in
2002(Cherry & Woodwell, 2002). In 2000, 44,619 deaths were
attributed directly to hypertension in this country, with
HTN playing a part in 118,000 more (“High Blood Pressure
Statistics,” 2003).
The
benefits of controlling even mild hypertension are well
accepted. Long-term reductions in mortality from coronary
artery and cerebrovascular disease of between 15–25% have
been reported in large-scale studies (Five-year Findings,
1979). Incidence of stroke, in
particular, can be sharply reduced by controlling
hypertension (DiGuiseppi, 1996).
Medical
Management
Treatment
of HTN with prescription drugs has steadily improved. A
class of drugs called ACE inhibitors are now often
prescribed as first line treatment. These drugs replaced
earlier use of diuretics and beta blockers, whose side
effects often led to noncompliance or poor compliance. Lack
of compliance with medications is still a major
complicating factor in treatment (Patel & Marmot,
1987).
Nonpharmacologic
management of hypertension
The
effectiveness and cost-effectiveness of behavioral
interventions, when combined with drug therapy, were shown
repeatedly in the 1980s (Agras, 1981; Crowther, 1983;
Ginsberg, Viskoper, et al, 1990; Patel & Marmot,
1987). Chief
among these interventions are exercise, weight loss
programs, and relaxation.
Behavioral approaches also have added advantages: improve
quality of life, better patient self-efficacy,
reduction in mortality, improved patient feeling of being
in control, and improved compliance with therapy
(“Five-year Findings,” 1979; Ginsberg, Viskoper, et al;
Lorig, Sobel, et al, 1999; Patel & Marmot).
Cognitive
Behavioral Therapy, even without a relaxation component, is
effective at reducing stress (Abgrall-Barbry & Consoli,
2005). Perhaps because of improvements in drug therapy,
behavioral approaches have not become mainstream in the
U.S.
Mind-Body Management of Hypertension
Guided
imagery is a highly effective behavioral intervention for
HTN. It combines deep relaxation with positive
self-suggestion, both of which reduce blood pressure
(Crowther, 1983; Taylor, Farquhar, et al, 1977).
Researchers from
the Centers for Disease Control and Prevention have stated
that “evidence for the efficacy of certain
non-pharmacologic approaches to preventing and controlling
HBP [high blood pressure] is strong” (Labarthe & Ayala,
2002).
Individual studies support the efficacy of imagery,
relaxation training, biofeedback with relaxation training,
hypnosis, and autogenic training (Herrmann, 2002; Nakao,
Yano, et al., 2003; Stetter & Kupper, 2002).These
results were further confirmed by two 2003 reviews of the
medical literature. One study found “moderate evidence of
efficicacy” for using mind body modalities (relaxation,
imagery, hypnosis, CBT) for managing HTN (Astin, Shapiro,
et al, 2003).
One researcher reported in his 2002 study that “relaxation
techniques (autogenic training or progressive muscular
relaxation, behavioral therapy or biofeedback techniques),
can lower elevated blood pressure by an average of 10 mmHg
(systolic) and 5 mmHg (diastolic)(Herrmann, 2002).
A review of 37
studies of the relaxation response confirmed its efficacy
(Mandle, Jacobs, et al, 1996).
Meditation (Barnes, Davis, et al, 2004; Barnes, Treiber et
al, 2004; Stefano & Esch, 2005; Vyas & Dikshit,
2002), relaxation, and stress reduction (Kurz, Potz, et al,
2005) have also proven beneficial. Breathing exercises can
also lower blood pressure (Bernardi, Spicuzza &
Sleight, 2005). In two studies of African American women,
meditation decreased blood pressure (Schneider, Alexander,
Staggers, Orme-Johnson et al, 2005), and significantly
decreased mortality (Schneider, Alexander, Staggers,
Rainforth, et al, 2005).
One review analyzed 22 biofeedback studies; it was found
that only relaxation-assisted biofeedback was able to
significantly decrease systolic and diastolic blood
pressures, leading the researchers to conclude that its
effect may have been from the relaxation component (Nakao,
Yano, et al., 2003.
Conclusion
A
low cost guided imagery program can be a valuable
complement to medical treatment of hypertension by
contributing to more effective management of blood
pressure, better adherence to therapy, decreased need of
doctor’s visits, and higher quality of life for patients.
References
Abgrall-Barbry G, Consoli SM.
[Psychological approaches in hypertension management]
[Article in French] Presse
Med.
2006 Jun;35(6 Pt 2):1088-94.
Agras WS. Behavioral approaches to the treatment of
essential hypertension. Int
J
Obes. 1981 5 suppl 1:173-81.
Astin JA, Shapiro SL, Eisenberg DM, Forys KL. Shapiro SL,
Eisenberg DM, Forys KL. Mind-body medicine: state of the
science, implications for practice. J Am Board Fam
Pract. 2003 Mar-Apr;16(2):131-47.
Barnes
VA, Davis HC, Murzynowski JB, Treiber FA. Impact of
meditation on resting and ambulatory blood pressure and
heart rate in youth. Psychosom
Med.
2004a Nov-Dec;66(6):909-14.
Barnes VA, Treiber FA, Johnson MH. Impact of transcendental
meditation on ambulatory blood pressure in African-American
adolescents. Am J
Hypertens. 2004b Apr;17(4):366-9.
Bernardi L, Porta C, Spicuzza
L, Sleight P. Cardiorespiratory interactions to external
stimuli. Arch Ital
Biol.
2005 Sep;143(3-4):215-21.
Cherry DK, Woodwell DA. National Ambulatory Medical Care
Survey: 2002 Summary. Advance data from vital and health
statistics; No. 328. Hyattsville, Maryland: National Center
for Health Statistics. 2002.
Crowther J. Stress management training and relaxation
imagery in the treatment of essential hypertension.
J Behavioral
Medicine. 1983 Jun 6(2) 169-187.
Dawber TF. (1980). The Framingham study: the
epidemiology of atherosclerotic
disease.
Cambridge, MA: Harvard University Press.
DiGuiseppi C, for the U.S. Preventative Services Task
Force. Screening for Hypertension. The Guide to Clinical
Preventive Services: Task Force, Second Edition 1996
(excerpt).
http://www.ahrq.gov/clinic/2ndcps/hperten.pdf
Accessed August, 2006.
[No
authors listed] Five-year findings of the Hypertension
Detection and Follow-Up Program. I. Reduction in mortality
of persons with high blood pressure, including mild
hypertension. Hypertension Detection and Follow-Up Program
Cooperative Group. JAMA.
1979 242:2562-2572.
Ginsberg GM, Viskoper RJ, Prem S, Bregman L, Mishal Y,
Sherf S. Resource savings from non-pharmacological control
of hypertension. J Human
Hypertension. 1990 Aug; 4 (4): 375-8.
[no authors listed] Heart Disease and Stroke Statistics —
2003 Update. Dallas, Tex.: American Heart Association.
2002.
www.americanheart.org/downloadable/heart/10461207852142003HDSStatsBook.pdf
Accessed August, 2006.
Herrmann JM. Essential hypertension and stress. When do
yoga, psychotherapy and autogenic training help? [Article
in German] MMW Fortschr
Med. 2002 May 9;144(19):38-41.
[no authors listed] High Blood Pressure Statistics.
American Heart Association. [undated].
http://www.americanheart.org/presenter.jhtml?identifier=2139
Accessed August, 2006.
Kurz RW, Pirker H, Potz H,
Dorrscheidt W, Uhlir H. [Evaluation of costs and
effectiveness of an integrated training program for
hypertensive patients.] [Article in German]
Wien Klin
Wochenschr. 2005 Aug;117(15-16):526-33.
Labarthe D, Ayala C. Nondrug interventions in hypertension
prevention and control. Cardiol Clin.
2002
May;20(2):249-63.
Lorig KR, Sobel DS, Stewart AL, Brown, Jr. BW, Ritter PL,
Gonzalez VM, Laurent DD, Holman HR. Evidence suggesting
that a chronic disease self-management program can improve
health status while reducing utilization and costs: A
randomized trial. Medical Care.
1999 37(1): 5–14.
Mandle CL, Jacobs SC, Arcari PM, Domar AD. The efficacy of
relaxation response interventions with adult patients: a
review of the literature [see comments].
Journal of
Cardiovascular Nursing. 1996 Apr, 10(3):4-26.
Nakao M, Yano E, Nomura S, Kuboki T. Blood
pressure-lowering effects of biofeedback treatment in
hypertension: a meta-analysis of randomized controlled
trials. Hypertens Res.
2003
Jan;26(1):37-46.
Ornish D. (1990). Dr. Dean Ornish's Guide to
Reversing Heart Disease. New York: Random House.
Patel C, Marmot M. Stress Management, Blood Pressure and
Quality of Life. Journal of
Hypertension. 1987 5 (supp 1): S21-S28.
Schneider RH, Alexander CN,
Staggers F, Orme-Johnson DW, Rainforth M, Salerno JW,
Sheppard W, Castillo-Richmond A, Barnes VA, Nidich SI. A
randomized controlled trial of stress reduction in African
Americans treated for hypertension for over one
year. Am
J Hypertens. 2005 Jan;18(1):88-98.
Schneider RH, Alexander CN, Staggers F, Rainforth M,
Salerno JW, Hartz A, Arndt S, Barnes VA, Nidich SI.
Long-term effects of stress reduction on mortality in
persons > or = 55 years of age with systemic
hypertension. Am J
Cardiol. 2005 May 1;95(9):1060-4.
Stefano GB, Esch T. Integrative
medical therapy: examination of meditation's therapeutic
and global medicinal outcomes via nitric oxide
(review). Int J Mol
Med.
2005 Oct;16(4):621-30.
Stetter F, Kupper S. Autogenic training: a meta-analysis of
clinical outcome studies. Appl Psychophysiol
Biofeedback, 2002 Mar;27(1):45-98.
Taylor CB, Farquhar JW, Nelson E, Agras S. Relaxation
therapy and high blood pressure. Archives of General
Psychiatry. 1977 34:339-42.
Vyas R, Dikshit N. Effect of meditation on respiratory
system, cardiovascular system and lipid profile.
Indian J
Physiol Pharmacol. 2002 Oct;46(4):487-91.
Yucha CB, Tsai PS, Calderon KS, Tian L.
Biofeedback-assisted relaxation training for essential
hypertension: who is most likely to benefit?
J Cardiovasc
Nurs.
2005 May-Jun;20(3):198-205.